Structure-based drug repurposing against COVID-19 and emerging infectious diseases: methods, resourc...
Structure-based drug repurposing against COVID-19 and emerging infectious diseases: methods, resources and discoveries
About this item
Full title
Author / Creator
Publisher
England: Oxford University Press
Journal title
Language
English
Formats
Publication information
Publisher
England: Oxford University Press
Subjects
More information
Scope and Contents
Contents
To attain promising pharmacotherapies, researchers have applied drug repurposing (DR) techniques to discover the candidate medicines to combat the coronavirus disease 2019 (COVID-19) outbreak. Although many DR approaches have been introduced for treating different diseases, only structure-based DR (SBDR) methods can be employed as the first therape...
Alternative Titles
Full title
Structure-based drug repurposing against COVID-19 and emerging infectious diseases: methods, resources and discoveries
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8194848
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8194848
Other Identifiers
ISSN
1467-5463
E-ISSN
1477-4054
DOI
10.1093/bib/bbab113
